Strive targets IPO of 5,000,000 shares of 15% Series A perpetual preferred stock
Bitget2026/10/13 20:35Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Strive plans an IPO of 5,000,000 shares of 15.00% Series A Perpetual SATS Preferred Stock.
- SATS Stock carries a $100 stated amount per share, cumulative dividends of 15.00% a year.
- Net proceeds earmarked for general corporate purposes, including bitcoin purchases, working capital, income-producing assets, capital spending, buybacks.
- Dividend reserve planned at closing, equal to 18 months of dividends, funded with $22.50 per share from cash, securities.
- Barclays, Cantor joint book-runners; Clear Street lead manager.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Strive Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-065737), on October 13, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%
Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.
智通财经•2026/10/25 02:56



Crypto prices
MoreBitcoin
BTC
$80,859.68
-0.02%
Ethereum
ETH
$2,363.97
-0.80%
Tether USDt
USDT
$0.9987
-0.00%
BNB
BNB
$744.25
+0.65%
XRP
XRP
$1.31
+1.40%
USDC
USDC
$0.9998
-0.01%
Solana
SOL
$102.36
-0.36%
TRON
TRX
$0.3285
-0.30%
Zcash
ZEC
$1,212.68
+3.79%
Hyperliquid
HYPE
$76.49
-0.95%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now